Original Research
Published on 29 Nov 2021
Interleukin-5 (IL-5) Therapy Prevents Allograft Rejection by Promoting CD4+CD25+ Ts2 Regulatory Cells That Are Antigen-Specific and Express IL-5 Receptor
in Immunological Tolerance and Regulation
Frontiers in Immunology
doi 10.3389/fimmu.2021.714838
- 6,062 views
- 10 citations
